<div><div></div><div>NeOnc Technologies entered into a Securities Purchase Agreement to sell up to 2,222,222 shares of common stock at $7.20 per share and issue five-year warrants to purchase up to 2,222,222 shares at $9.00 per share. An initial closing delivered 1,388,888 shares and matching warrants to a single institutional investor for $10 million, with additional closings expected. The company will file a resale registration statement within 10 days of the initial closing. Net proceeds will be used to repay debt and for working capital.Agreement details:<ul><li>Agreement type: Private placement Securities Purchase Agreement for common stock and warrants</li><li>Counterparty: Institutional Investor</li><li>Signed / Effective: Jan 29 2026 / same</li><li>Duration / Termination: 5 years (warrants)</li><li>Reason: Raise capital to repay debt and fund operations</li></ul>Original SEC Filing: NEONC TECHNOLOGIES HOLDINGS, INC. [ NTHI ] - 8-K - Jan. 29, 2026<section>Disclaimer<div>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</div></section></div></div>

NTHI

SBIO

ARKG

NeOnc Technologies has signed a Securities Purchase Agreement to sell up to 2,222,222 shares of common stock at $7.20 each and issue five-year warrants for the same number of shares at $9.00 each. An initial closing has provided $10 million from a single institutional investor for 1,388,888 shares and matching warrants. The company plans to use the net proceeds for debt repayment and working capital, with additional closings anticipated. A resale registration statement will be filed within 10 days of the initial closing.

TradingView

VanEck Biotech ETF

Neonc Tech

Proshares Ultra Nasdaq Biotech

SPDR S&P Biotech

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

Ark Genomic Revolution ETF

Invesco Biotechnology & Genome ETF

NeOnc Technologies Signs Securities Purchase Agreement With Institutional Investor